FTC sues big pharmacy gain managers in excess of insulin price ranges The company introduced motion against Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the list price of lifestyle-saving insulin medicines. Insurers will continue on vertically integrating to maintain extra earnings in-house, https://dave-s-hot-chicken-nutrit84951.ampblogs.com/the-5-second-trick-for-healthcare-news-67460358